By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.




Founder: Edward Robinson Squibb

CEO: Giovanni Caforio, MD

CFO: Charles Bancroft


Please click here for clinical trial information.


Please click here for Bristol-Myers Squibb job opportunities.


Please click here to see all products.

For more information, visit and follow us on


Key Statistics

Ownership: Public

Web Site: Bristol-Myers Squibb
Symbol: BMY



PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead (Durham, NC) 

Phyton Biotech  - Cancer

Gilead (Seattle, WA) 

Company News
Bristol-Myers Squibb (BMY) Receives Positive CHMP Opinion Recommending Opdivo (Nivolumab) For The Treatment Of Squamous Cell Cancer Of The Head And Neck In Adults Progressing On Or After Platinum-Based Therapy 3/24/2017 6:57:09 AM
Why Struggling Bristol-Myers Squibb (BMY) Could Take Out This Danish Biotech in Major €500M Deal 3/21/2017 6:05:48 AM
Bay Area's CytomX (CTMX) Surges as Bristol-Myers Squibb (BMY) Signs Up for 8 More Projects With $200 Million Upfront in Deal Totaling $5 Billion 3/20/2017 5:47:05 AM
Bristol-Myers Squibb (BMY) And Pfizer (PFE) Present Large Real-World Observational Analysis Of The Effectiveness And Safety Of Direct Oral Anticoagulants Compared To Warfarin In Patients With Non-Valvular Atrial Fibrillation 3/17/2017 9:27:28 AM
Bristol-Myers Squibb (BMY) To Announce Results For First Quarter 2017 On April 27 3/10/2017 8:55:31 AM
Painful Setbacks Lead Bristol-Myers Squibb (BMY) to Bring in a New R&D Chief 3/8/2017 12:03:41 PM
What Illumina (ILMN)'s And Bristol-Myers Squibb (BMY)'s Latest GRAIL Moves Mean For Investors 3/8/2017 6:19:44 AM
Bristol-Myers Squibb (BMY) And Pfizer (PFE) To Present New Analyses Of Eliquis (Apixaban) Clinical And Real-World Data At American College of Cardiology 2017 Scientific Session 3/6/2017 7:28:49 AM
Following Up on Bristol-Myers Squibb (BMY)'s Restructuring Plans, Company Makes Move to Shift 1,250 Workers Out of Hopewell Township Site 3/3/2017 7:04:53 AM
Bristol-Myers Squibb (BMY) Announces Dividend 3/3/2017 6:51:18 AM